Migrenofen (Rizatriptan Benzoate)

Rizatriptan works by binding to serotonin 5‑HT1B and 5‑HT1D receptors in the brain. Activation of these receptors causes constriction of dilated cranial blood vessels and blocks the release of pain‑triggering neuropeptides, thereby interrupting the migraine pain pathway.

The dose of Migrenofen is determined by the prescribing healthcare professional based on the individual’s medical condition, response to therapy, and other factors. The prescriber will select the appropriate strength and timing according to current clinical guidelines.

Safety data for rizatriptan during pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made in consultation with a qualified healthcare provider.

To order Migrenofen, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Both Migrenofen (rizatriptan) and sumatriptan belong to the triptan class and act on 5‑HT1B/1D receptors. Rizatriptan generally has a slightly longer half‑life and may provide more sustained relief for some patients, while sumatriptan often has a faster onset but a shorter duration of action.

Migrenofen tablets should be stored at room temperature, below 25 °C, in their original container. Keep them away from moisture, excessive heat and direct sunlight to maintain product stability throughout its shelf life.

Migrenofen is taken orally as a tablet. The tablet should be swallowed whole with a glass of water. It may be taken with or without food, but patients should follow the specific instructions provided by their prescriber.

The most serious risks include serotonin syndrome, which can be life‑threatening, coronary vasospasm leading to reduced blood flow to the heart, and severe allergic reactions such as anaphylaxis. Patients should seek immediate medical attention if they experience chest pain, severe dizziness, or signs of an allergic reaction.

Migrenofen should be avoided in patients with a history of uncontrolled hypertension, coronary artery disease, previous stroke or transient ischemic attack, peripheral vascular disease, or known hypersensitivity to rizatriptan or any other triptan. It is also contraindicated when used with certain serotonergic drugs.